Tafas v. Dudas et al
Filing
177
AMICUS Brief Exhibits in Support of Plaintiffs Motion for Summary Judgment by Polestar Capital Associates, LLC, Norseman Group, LLC re 173 Amicus Brief, Exhibits 13-20 to Amici Brief in Support of Summary Judgment (Attachments: # 1 Exhibit 13# 2 Exhibit 14# 3 Exhibit 15# 4 Exhibit 16.1# 5 Exhibit 16.2# 6 Exhibit 17# 7 Exhibit 18# 8 Exhibit 19# 9 Exhibit 20.1# 10 Exhibit 20.2)(Franco, Craig) Modified text on 12/31/2007 (klau, ). Modified on 1/9/2008 to reflect Exhibits to Amicus Brief (klau, ).
Tafas v. Dudas et al
Doc. 177 Att. 9
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 1 of 21
Exhibit 20
Comment Letter of Heritage Woods, Inc. (May 2, 2006)
Part 1: Pages 1-16, P000580-95
Dockets.Justia.com
Comments Regarding Continuation Practice
http://www.uspto.gov/web/offices/pac/dapp/opla/comments/fpp_continuation/continuation_c...
United States Patent and Trademark Office
Home|Site Index|Search|FAQ|Glossary|Guides|Contacts|eBusiness|eBiz alerts|News|Help
PATENTS
Patents > Office of the Deputy Commissioner for Patent Examination Policy > Office of Patent Legal Administration > Proposed Rule Changes to Focus the Patent Process in the 21st Century > Comments Regarding Continuation Practice
Comments on Proposed Changes to Practice for Continuing Applications, Requests for Continued Examination Practice, and Applications Containing Patentably Indistinct Claims, Notice of proposed rulemaking Prior to May 6, 2006, the organizations and persons listed below have submitted comments in response to the Proposed Changes to Practice for Continuing Applications, Requests for Continued Examination Practice, and Applications Containing Patentably Indistinct Claims, Notice of proposed rulemaking, first published in the Federal Register at 71 Fed. Reg. 48 (January 3, 2006) and then published in the Official Gazette at 1302 Off. Gaz. Pat. Office 1318 (January 24, 2006). It is hoped that the public will review this list of comments submitted prior to May 6, 2006, to determine if it is complete. If any person or organization has submitted comments prior to May 6, 2006, but is not included in this listing, please submit the comment by electronic mail message to Robert.Clarke@uspto.gov, or contact Robert A. Clarke by telephone at (571) 272-7735. The comments below are grouped into the following categories: intellectual property organizations, government agencies, corporations, and individuals. Each comment is attributed to the individual submitting the comment unless the comment indicates it is made on behalf of an organization. Please note that the following documents are provided as submitted by persons and organizations but may contain spelling corrections, artifacts of scanning, OCR, or document format conversion. A. Intellectual Property Organizations and Government Agencies 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. ABA-Intellectual Property Law [PDF] American Intellectual Property Law Association (AIPLA) [PDF] Bar Association of the District of Columbia, PTC Section [PDF] Boston Patent Law Association, Committee on Patent Office Practice [PDF] Houston Intellectual Property Law Association (HIPLA) [PDF] Intellectual Property Law Association of Chicago (IPLAC) [PDF] Intellectual Property Owners Association (IPO) [PDF] Intellectual Ventures, LLC [PDF] Inventors Alliance [PDF] Japanese Intellectual Property Association (JIPA) [PDF] Los Angeles Intellectual Property Law Association (LAIPLA) [PDF] Minnesota Intellectual Property Law Association (MIPLA), Chemical and Biotech Practice Committee [PDF] Minnesota Intellectual Property Law Association (MIPLA), Intellectual Property Law Revisions Committee [PDF] Minnesota Intellectual Property Law Association (MIPLA), Patent Prosecution Committee [PDF] National Association of Patent Practitioners (NAPP) [PDF] New York Intellectual Property Law Association (NYIPLA) [PDF] North Carolina Bar Association, Intellectual Property Law Section [PDF] Northern Virginia Patent Lawyers Club (NVPLC) [PDF] Ohio State Bar Association, Intellectual Property Law Section [PDF] Oregon Patent Law Association (OPLA) [PDF]
1 of 9
12/27/2007 1:24 AM
Comments Regarding Continuation Practice
http://www.uspto.gov/web/offices/pac/dapp/opla/comments/fpp_continuation/continuation_c...
21. 22. 23. 24. 25. 26. 27. 28. 29.
Patent Public Advisory Committee of the USPTO [PDF] Pennsylvania Intellectual Property Forum [PDF] Philadelphia Intellectual Property Law Association [PDF] San Diego Intellectual Property Law Association (SDIPLA) [PDF] U.S. Department of Juustice, Antitrust Division [PDF] U.S. Federal Trade Commission (FTC) [PDF] U.S. National Institute of Health, HHS [PDF] U.S. Small Business Administration (SBA), Office of Advocacy (Advocacy) [PDF] Washington State Patent Law Association [PDF]
B. Corporations and Associations 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 3M Innovative Properties Company [PDF] Affymetrix, Inc. [PDF] Altera Corporation [PDF] Amgen [PDF] Amylin Pharmaceuticals, Inc. [PDF] Anatomic Research, Inc. [PDF] Apple Computer, Inc. [PDF] Aradigm Corporation [PDF] Bally Technologies [PDF] BASF AG [PDF] Biogen Idec, Inc. [PDF] Biotechnology Industry Organization (BIO) [PDF] Brigham and Women's Hospital - CSRL [PDF] Burnham Institute for Medical Research [PDF] Business Software Alliance (BSA) [PDF] California Healthcare Institute (CHI) [PDF] Caterpillar Inc. [PDF] CCIA [PDF] Ceres, Inc. [PDF] Cisco Systems [PDF] Clarcor, Inc. [PDF] Council on Government Relations [PDF] Eastman Kodak Company [PDF] eBay, Inc. [PDF] E. I. du Pont Nemours and Company [PDF] Eli Lilly and Company [PDF] Fallbrook Technologies, Inc. [PDF] Genentech, Inc. [PDF] GlaxoSmithKline [PDF] Heritage Woods, Inc. [PDF] Honda R&D Americas, Inc. [PDF] Human Genome Sciences, Inc. [PDF] IBM Corporation [PDF] Intel Corporation [PDF]
2 of 9
12/27/2007 1:24 AM
Comments Regarding Claims Practice
http://www.uspto.gov/web/offices/pac/dapp/opla/comments/fpp_claims/claims_comments.html
United States Patent and Trademark Office
Home|Site Index|Search|FAQ|Glossary|Guides|Contacts|eBusiness|eBiz alerts|News|Help
PATENTS
Patents > Office of the Deputy Commissioner for Patent Examination Policy > Office of Patent Legal Administration > Proposed Rule Changes to Focus the Patent Process in the 21st Century > Comments Regarding Claims Practice
Prior to May 6, 2006, the organizations and persons listed below have submitted comments in response to the Changes to Practice for the Examination of Claims in Patent Applications, Notice of proposed rule making, first published in the Federal Register at 71 Fed. Reg. 61 (January 3, 2006) and then published in the Official Gazette at 1302 Off. Gaz. Pat. Office 1329 (January 24, 2006). It is hoped that the public will review this list of comments submitted prior to May 6, 2006, to determine if it is complete. If any person or organization has submitted comments prior to May 6, 2006, but is not included in this listing, please submit the comment by electronic mail message to Robert.Clarke@uspto.gov, or contact Robert A. Clarke by telephone at (571) 272-7735. The comments below are grouped into the following categories: intellectual property organizations, government agencies, corporations, and individuals. Each comment is attributed to the individual submitting the comment unless the comment indicates it is made on behalf of an organization. Please note that the following documents are provided as submitted by persons and organizations but may contain spelling corrections, artifacts of scanning, OCR, or document format conversion. A. Intellectual Property Organizations and Government Agencies 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. ABA-Intellectual Property Law [PDF] American Intellectual Property Law Association (AIPLA) [PDF] Bar Association of the District of Columbia, PTC Section [PDF] Boston Patent Law Association, Committee on Patent Office Practice [PDF] Japanese Intellectual Property Association (JIPA) [PDF] Intellectual Property Law Association of Chicago (IPLAC) [PDF] Intellectual Property Owners Association (IPO) [PDF] Intellectual Ventures, LLC [PDF] Inventors Alliance [PDF] Minnesota Intellectual Property Law Association (MIPLA), Chemical and Biotech Practice Committee [PDF] Minnesota Intellectual Property Law Association (MIPLA), Intellectual Property Law Revisions Committee [PDF] Minnesota Intellectual Property Law Association (MIPLA), Patent Prosecution Committee [PDF] National Association of Patent Practitioners (NAPP) [PDF] New York Intellectual Property Law Association (NYIPLA) [PDF] North Carolina Bar Association, Intellectual Property Law Section [PDF] Northern Virginia Patent Lawyers Club (NVPLC) [PDF] Ohio State Bar Association, Intellectual Property Law Section [PDF] Oregon Patent Law Association (OPLA) [PDF] Patent Public Advisory Committee of the USPTO [PDF] Pennsylvania Intellectual Property Forum [PDF] Philadelphia Intellectual Property Law Association [PDF] San Diego Intellectual Property Law Association (SDIPLA) [PDF] U.S. Department of Juustice, Antitrust Division [PDF]
1 of 6
12/27/2007 1:22 AM
Comments Regarding Claims Practice
http://www.uspto.gov/web/offices/pac/dapp/opla/comments/fpp_claims/claims_comments.html
24. U.S. Small Business Administration (SBA), Office of Advocacy (Advocacy) [PDF] 25. Washington State Patent Law Association [PDF] B. Corporations and Associations 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 3M Innovative Properties Company [PDF] Altera Corporation [PDF] Amgen [PDF] Amylin Pharmaceuticals, Inc. [PDF] Anatomic Research, Inc. [PDF] Apple Computer, Inc. [PDF] Bally Technologies [PDF] BASF AG [PDF] Biogen Idec, Inc. [PDF] Biotechnology Industry Organization (BIO) [PDF] Brigham and Women's Hospital - CSRL [PDF] Caterpillar Inc. [PDF] Council on Government Relations [PDF] Eastman Kodak Company [PDF] E. I. du Pont Nemours and Company [PDF] Eli Lilly and Company [PDF] GlaxoSmithKline [PDF] Heritage Woods, Inc. [PDF] Human Genome Sciences, Inc. [PDF] IBM Corporation [PDF] InterDigital Communication Corporation [PDF] Massachussetts General Hospital-CSRL [PDF] Maxygen, Inc. [PDF] Medarex, Inc. [PDF] Microsoft Corporation [PDF] Miller Patent Services [PDF] National Venture Capital Association [PDF] Novartis Vaccines Diagnostics, Inc. [PDF] Pfizer, Inc. [PDF] Pharmaceutical Research and Manufacturers of America (PhRMA) [PDF] SanDisk Corporation [PDF] Telik, Inc. [PDF] Texas Instruments [PDF] University of California [PDF] Walker Digital Management, LLC [PDF] Wisconsin Alumni Research Foundation [PDF] Wyeth [PDF] ZymoGenetics, Inc. [PDF]
C. Law Firms 1. Bachman & LaPointe, PC [PDF]
2 of 6
12/27/2007 1:22 AM
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 6 of 21
P000580
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 7 of 21
P000581
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 8 of 21
P000582
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 9 of 21
P000583
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 10 of 21
P000584
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 11 of 21
P000585
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 12 of 21
P000586
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 13 of 21
P000587
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 14 of 21
P000588
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 15 of 21
P000589
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 16 of 21
P000590
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 17 of 21
P000591
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 18 of 21
P000592
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 19 of 21
P000593
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 20 of 21
P000594
Case 1:07-cv-00846-JCC-TRJ
Document 177-10
Filed 12/27/2007
Page 21 of 21
P000595
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?